MRK vs AMGN
By Alex · Tickerpine
Merck & Co., Inc. vs Amgen Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | AMGN |
|---|---|---|
| Price | $147.76 | $465.67 |
| Market cap | $364.26B | $251.89B |
| P/E ratio | 149.3 | 27.0 |
| ROE | 5.06% | 78.35% |
| Profit margin | 3.64% | 24.14% |
| Revenue growth | 4.70% | 8.50% |
| Dividend yield | 2.30% | 2.16% |
| Beta | 0.12 | 0.42 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs AMGN in plain English
- MRK is the bigger company — about 1.4× the market cap of AMGN.
- AMGN is cheaper on earnings (P/E 27.0 vs 149.3).
- AMGN earns a higher return on equity (78% vs 5%).
- AMGN is growing revenue faster (8% vs 5%).
- MRK has the higher dividend yield (2.30% vs 2.16%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.